Waidyanatha Suramya, Mutlu Esra, Gibbs Seth, Pierfelice Jessica, Smith Jeremy P, Burback Brian, Blystone Chad T
Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA.
Battelle Memorial Institute, Columbus, OH, USA.
Xenobiotica. 2021 Jul;51(7):831-841. doi: 10.1080/00498254.2021.1927239. Epub 2021 May 24.
Phenolic benzotriazoles are ultraviolet-light absorbers used in a variety of industrial and consumer applications. We investigated the toxicokinetic behaviour of 9 compounds, covering unsubstituted, monosubstituted, disubstituted, and trisubstituted compounds, following a single gavage (30 and 300 mg/kg) and intravenous (IV) (2.25 mg/kg) administration in male rats.Following IV administration, no distinct pattern in plasma elimination was observed for the compounds with half-lives ranging from 15.4-84.8 h. Systemic exposure parameters, maximum concentration (C) and area under the concentration time curve (AUC), generally increased with the degree of substitution.Following gavage administration, C and AUC of unsubstituted compound were lower compared to the substituted compounds. C and AUC increased ≤7-fold with a 10-fold increase in the dose except for the AUC of the unsubstituted compound where the increase was 30-fold. Plasma elimination half-lives for the class ranged from 1.57 to 192 h with the exception of 30 mg/kg drometrizole.Oral bioavailability was low with ∼ 6% estimated for unsubstituted compound and 12.8-23% for others at 30 mg/kg dose. Bioavailability was lower following administration of the higher dose.Taken collectively, these data point to low oral absorption of phenolic benzotriazoles. The absorption decreased with increasing dose. Substituted compounds may be less metabolized compared to the unsubstituted.
酚类苯并三唑是用于各种工业和消费应用的紫外线吸收剂。我们研究了9种化合物的毒代动力学行为,这些化合物涵盖未取代、单取代、二取代和三取代化合物,在雄性大鼠中单次灌胃(30和300mg/kg)和静脉注射(IV)(2.25mg/kg)后进行观察。静脉注射后,观察到这些化合物的血浆消除没有明显模式,半衰期范围为15.4 - 84.8小时。全身暴露参数,即最大浓度(C)和浓度-时间曲线下面积(AUC),一般随着取代程度的增加而增加。灌胃给药后,未取代化合物的C和AUC低于取代化合物。除未取代化合物的AUC增加30倍外,剂量增加10倍时,C和AUC增加≤7倍。该类化合物的血浆消除半衰期范围为1.57至192小时,但30mg/kg剂量的屈美通除外。口服生物利用度较低,在30mg/kg剂量下,未取代化合物的估计生物利用度约为6%,其他化合物为12.8 - 23%。给予较高剂量后生物利用度较低。总体而言,这些数据表明酚类苯并三唑的口服吸收较低。吸收随着剂量增加而降低。与未取代化合物相比,取代化合物的代谢可能较少。